These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3909313)

  • 1. Management of infections caused by gram-negative bacilli: the role of antimicrobial combinations.
    Allan JD; Moellering RC
    Rev Infect Dis; 1985; 7 Suppl 4():S559-71. PubMed ID: 3909313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial combinations in the therapy of infections due to gram-negative bacilli.
    Allan JD; Moellering RC
    Am J Med; 1985 Feb; 78(2A):65-76. PubMed ID: 3918445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism and antagonism.
    Eliopoulos GM
    Infect Dis Clin North Am; 1989 Sep; 3(3):399-406. PubMed ID: 2671129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.
    García-Rodríguez JA; García Sánchez JE; García García MI; García Sánchez E; Muñoz Bellido JL
    Diagn Microbiol Infect Dis; 1991; 14(3):239-43. PubMed ID: 1889176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic considerations in using combinations of newer beta-lactam antibiotics.
    Barriere SL
    Clin Pharm; 1986 Jan; 5(1):24-33. PubMed ID: 3512153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic synergism and antimicrobial combinations in clinical infections.
    Eliopoulos GM; Moellering RC
    Rev Infect Dis; 1982; 4(2):282-93. PubMed ID: 7051231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concept of empiric therapy with antibiotic combinations. Indications and limits.
    Klastersky J
    Am J Med; 1986 May; 80(5C):2-12. PubMed ID: 3521271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ; Jin YF; Turner HL
    J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
    Mohanty S; Singhal R; Sood S; Dhawan B; Das BK; Kapil A
    Indian J Med Res; 2005 Nov; 122(5):425-8. PubMed ID: 16456257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale for use of antimicrobial combinations.
    Moellering RC
    Am J Med; 1983 Aug; 75(2A):4-8. PubMed ID: 6351605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a role for monotherapy with beta-lactam antibiotics in the initial empirical management of febrile neutropenic cancer patients?
    Hathorn JW; Pizzo PA
    J Antimicrob Chemother; 1986 Mar; 17 Suppl A():41-54. PubMed ID: 3519563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
    Walsh TJ; Schimpff SC
    Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethoprim-sulfamethoxazole.
    Cockerill FR; Edson RS
    Mayo Clin Proc; 1983 Mar; 58(3):147-53. PubMed ID: 6600803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empiric antibiotic therapy for granulocytopenic cancer patients.
    Schimpff SC
    Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocompromised animal models for the study of antibiotic combinations.
    Calandra T; Glauser MP
    Am J Med; 1986 May; 80(5C):45-52. PubMed ID: 3087166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-lactam/aminoglycoside combinations: interactions and their mechanisms.
    Moellering RC; Eliopoulos GM; Allan JD
    Am J Med; 1986 May; 80(5C):30-4. PubMed ID: 3717186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-lactam/beta-lactamase inhibitor combinations: pharmacodynamic considerations and possible role in the management of bacterial infections in the neutropenic host.
    Okereke C; Dudley MN
    J Antimicrob Chemother; 1998 Jun; 41 Suppl D():43-9. PubMed ID: 9688450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli.
    Pitout JD; Sanders CC; Sanders WE
    Am J Med; 1997 Jul; 103(1):51-9. PubMed ID: 9236486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethoprim-sulfamethoxazole.
    Cockerill FR; Edson RS
    Mayo Clin Proc; 1987 Oct; 62(10):921-9. PubMed ID: 3498863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parenteral beta-lactamase inhibitor combinations for clinical use.
    Manzella JP
    Am Fam Physician; 1995 May; 51(7):1695-8. PubMed ID: 7754928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.